Literature DB >> 16204387

Methylphenidate may treat apathy independent of depression.

Prasad R Padala1, Frederick Petty, Subhash C Bhatia.   

Abstract

OBJECTIVE: To report a case of apathy treated with methylphenidate in which improvement in apathy was independent of improvement of depression. CASE
SUMMARY: A 47-year-old woman with a 20-year history of recurrent major depression was diagnosed as having significant apathy with lack of initiative and motivation. Over the course of a 4-week treatment regimen with methylphenidate, her apathy, as measured by the Apathy Evaluation Scale, improved, with her score decreasing from 57 to 31. During this period, her depression, as assessed by the 21-item Hamilton Rating Scale for Depression, remained unchanged. DISCUSSION: Our report of improvement of apathy with methylphenidate is consistent with other reports in the literature, although previous studies have not specifically used the rating scales to assess apathy. Even though this patient had experienced apathy for a long time, it had not been detected due to lack of direct questioning. In this case, as noted, the improvement of apathy was independent of improvement in depression.
CONCLUSIONS: A high degree of suspicion and specific inquiry is required for identification of apathy. Once detected, methylphenidate may be beneficial in its treatment, a strategy that may work independently of augmentation of antidepressants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204387     DOI: 10.1345/aph.1G352

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  6 in total

Review 1.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

2.  Methylphenidate-induced akathisia in a patient with multiple sclerosis.

Authors:  Maria S Almeida; Prasad R Padala; Subhash Bhatia
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 3.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

4.  Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease.

Authors:  Michelle A Babicz; Steven Paul Woods; Pariya Fazeli; Erin E Morgan
Journal:  J Clin Psychol Med Settings       Date:  2021-06

5.  The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.

Authors:  Roberta W Scherer; Lea Drye; Jacobo Mintzer; Krista Lanctôt; Paul Rosenberg; Nathan Herrmann; Prasad Padala; Olga Brawman-Mintzer; William Burke; Suzanne Craft; Alan J Lerner; Allan Levey; Anton Porsteinsson; Christopher H van Dyck
Journal:  Trials       Date:  2018-01-18       Impact factor: 2.279

6.  Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study.

Authors:  Prasad R Padala; Kalpana P Padala; Anusha S Majagi; Kimberly K Garner; Richard A Dennis; Dennis H Sullivan
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.